Ralometostat

N/A

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameRalometostat
Drug Alias NameTNG-908
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsSolid tumoursAdenocarcinoma of LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTango Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTango Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAdenocarcinoma of Lung
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A